Crizotinib superior to chemo for advanced ALK positive NSCLC

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery

Paclitaxel dosing equally effective in preventing breast cancer progression

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer

Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer

Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer

Extended use of tamoxifen reduces breast cancer recurrence and death

Ipilimumab and BRAF inhibitors for advanced melanoma

Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death

No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma

Bevacizumab extends survival for relapsed and advanced cervical cancer

Lapatinib in combination with chemotherapy in breast cancer